2-[1-[(2-FLUOROPHENYL)METHYL]-5-(3-ISOXAZOLYL)-1H-PYRAZOL-3-YL]-PYRIMIDINE DERIVATIVES AND RELATED COMPOUNDS AS SOLUBLE GUANYLATE CYCLASE (SGC) STIMULATORS FOR THE TREATMENT OF PULMONARY HYPERTENSION
申请人:Ironwood Pharmaceuticals, Inc.
公开号:EP3112363A1
公开(公告)日:2017-01-04
2-[1-[(2-Fluorophenyl)methyl]-5-(3-isoxazolyl)-1H-pyrazol-3-yl]-pyrimidine derivatives and related compounds as soluble guanylate cyclase (sGC) stimulators, particularly NO-independent, heme-dependent stimulators, for treating pulmonary hypertension and other diseases.
2-[1-[(2-氟苯基)甲基]-5-(3-异恶唑基)-1H-吡唑-3-基]-嘧啶衍生物及相关化合物,作为可溶性鸟苷酸环化酶(sGC)刺激剂,特别是 NO 依赖性、血红素依赖性刺激剂,用于治疗肺动脉高压和其他疾病。